Explore more publications!
Health Update Bahamas
Submit Press Release

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 1, 2025

Visory Health genera ahorros de 790 millones de dólares en medicamentos cardiovasculares esenciales
October 1, 2025

Visory Health genera ahorros de 790 millones de dólares en medicamentos cardiovasculares esenciales

Indeterminate GlobeNewswire
New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk
October 1, 2025

New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
October 1, 2025

TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors

Indeterminate GlobeNewswire
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
October 1, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine

Indeterminate GlobeNewswire
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
October 1, 2025

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
October 1, 2025

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

Indeterminate GlobeNewswire
NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
October 1, 2025

NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage

Indeterminate GlobeNewswire
Vital Nutrients Expands Clinical Line With New Formula for Women’s Hair Health
October 1, 2025

Vital Nutrients Expands Clinical Line With New Formula for Women’s Hair Health

Indeterminate GlobeNewswire
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy
October 1, 2025

POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy

Indeterminate GlobeNewswire
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
October 1, 2025

Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference

Indeterminate GlobeNewswire
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
October 1, 2025

Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025

Indeterminate GlobeNewswire
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
October 1, 2025

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Indeterminate GlobeNewswire
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
October 1, 2025

George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors

Indeterminate GlobeNewswire
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 1, 2025

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Indeterminate GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Artelo Biosciences Announces Closing of $2.0 Million Public Offering
October 1, 2025

Artelo Biosciences Announces Closing of $2.0 Million Public Offering

Indeterminate GlobeNewswire
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2025

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten
October 1, 2025

Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions